对分化型甲状腺癌(DTC)患者在随访期内进行动态风险评估是密切结合疾病特点而提出的新理念,是向疾病个体化、精确化诊治管理方向迈出的关键、坚实一步。笔者全面阐述DTC动态风险评估的发展历程、指南立场、根据评估结果的后续管理建议,以及现有风险分层的局限性和未来展望。 The dynamic risk assessment of patients with differentiated thyroid cancer (DTC) during the follow-up period is a new idea put forward in close connection with the characteristics of the disease and is a solid step forward in the direction of the individual diagnosis and management of disease. The author expounds in detail the development process of DTC dynamic risk assessment, the guidance position, the follow-up management suggestions based on the assessment results, as well as the limitations and future prospects of the existing risk stratification.